Free Trial
→ The chokepoint supplier behind SpaceX's $1.75 trillion empire (From Behind the Markets) (Ad)tc pixel Free EYPT Stock Alerts

Eyepoint Pharmaceuticals (EYPT) Short Interest Ratio & Short Volume

Eyepoint Pharmaceuticals logo
$11.76 -0.60 (-4.82%)
As of 02:49 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Eyepoint Pharmaceuticals Short Interest Overview

As of April 30, 2026, Eyepoint Pharmaceuticals (EYPT) had a short interest of 14.19 million shares sold short, representing 17.72% of the public float. This marks a 3.86% increase in short interest since the prior report. The short interest ratio (days to cover) is 16.6, meaning it would take 16.6 days of the average trading volume of 1.18 million shares to cover all short positions.

Current Short Interest
14,186,473 shares
Previous Short Interest
13,659,042 shares
Change Vs. Previous Month
3.86%
Dollar Volume Sold Short
$187.26 million
Short Interest Ratio
16.6 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
83,840,000 shares
Short Percent of Float
17.72%
Today's Trading Volume
449,808 shares
Average Trading Volume
1,180,312 shares
Today's Volume Vs. Average
38%
Short Selling Eyepoint Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Eyepoint Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

EYPT Short Interest Over Time

EYPT Days to Cover Over Time

EYPT Percentage of Float Shorted Over Time

Eyepoint Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202614,186,473 shares $187.26 million +3.9%17.7%16.59 $13.20
4/15/202613,659,042 shares $199.83 million +2.0%17.1%15.93 $14.63
3/31/202613,385,952 shares $172.54 million +7.3%16.8%14.06 $12.89
3/13/202612,478,689 shares $164.72 million +14.8%15.7%7.52 $13.20
2/27/202610,868,767 shares $190.86 million +14.1%13.6%4.51 $17.56
2/13/20269,529,005 shares $123.31 million +10.3%12.0%7.86 $12.94
1/30/20268,638,845 shares $116.80 million +4.4%10.9%9.51 $13.52
1/15/20268,272,026 shares $131.03 million -4.2%10.5%8.54 $15.84
12/31/20258,632,273 shares $157.71 million +18.1%10.9%6.61 $18.27
12/15/20257,308,090 shares $119.85 million -7.3%9.2%6.63 $16.40
11/28/20257,881,028 shares $116.88 million -8.7%10.0%7.08 $14.83
11/14/20258,632,226 shares $99.96 million +14.2%13.1%5.88 $11.58
10/31/20257,558,136 shares $98.94 million -7.0%11.5%5.85 $13.09
10/15/20258,130,000 shares $95.36 million +1.6%12.3%8.1 $11.73
9/30/20258,000,000 shares $113.92 million -10.0%N/A9.6 $14.24
9/15/20258,890,000 shares $119.21 million +5.2%N/A11.2 $13.41
8/31/20258,450,000 shares $97.77 million +9.9%12.8%11.5 $11.57
8/15/20257,690,000 shares $85.28 million +11.3%N/A9.8 $11.09
7/31/20256,910,000 shares $67.86 million +2.8%10.5%8.9 $9.82
7/15/20256,720,000 shares $66.12 million -3.0%N/A8.4 $9.84
6/30/20256,930,000 shares $65.21 million +2.8%10.5%8.3 $9.41
6/15/20256,740,000 shares $60.86 million -6.0%10.3%8.1 $9.03
5/31/20257,170,000 shares $51.70 million -0.6%11.0%8.6 $7.21
5/15/20257,210,000 shares $41.24 million -28.4%11.1%9.2 $5.72
4/30/202510,070,000 shares $68.68 million -14.8%N/A12.4 $6.82
4/15/202511,820,000 shares $67.02 million +8.1%18.2%14 $5.67
3/31/202510,930,000 shares $59.24 million +0.9%16.8%12.8 $5.42
3/15/202510,830,000 shares $70.61 million +0.9%16.7%12.6 $6.52
2/28/202510,730,000 shares $67.28 million -3.3%16.5%12.4 $6.27
2/15/202511,090,000 shares $72.09 million +3.5%17.1%12.3 $6.50
1/31/202510,720,000 shares $82.01 million +1.3%N/A11.9 $7.65
1/15/202510,580,000 shares $81.36 million +2.3%N/A11 $7.69
12/31/202410,340,000 shares $77.03 million +9.9%N/A10.8 $7.45
12/15/20249,410,000 shares $70.20 million +1.7%N/A10.3 $7.46
11/30/20249,250,000 shares $81.86 million -6.4%N/A10.8 $8.85
11/15/20249,880,000 shares $90.60 million +2.1%N/A12.2 $9.17
10/31/20249,680,000 shares $113.84 million +5.6%N/A13.1 $11.76
10/15/20249,170,000 shares $90.60 million +2.7%N/A15.9 $9.88
9/30/20248,930,000 shares $71.35 million -1.9%N/A13.8 $7.99
9/15/20249,100,000 shares $82.81 million -0.1%N/A12.8 $9.10
Read this warning immediately (Ad)

Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Read Porter Stansberry's full breakdown and protect your wealth now
8/31/20249,110,000 shares $81.53 million -3.9%N/A12.6 $8.95
8/15/20249,480,000 shares $77.74 million -0.7%N/A11.6 $8.20
7/31/20249,550,000 shares $94.35 million -5.3%N/A10.7 $9.88
7/15/202410,080,000 shares $106.24 million +4.7%N/A8.8 $10.54
6/30/20249,630,000 shares $83.78 million +7.2%N/A8.5 $8.70
6/15/20248,980,000 shares $84.23 million +16.0%N/A8.2 $9.38
5/31/20247,740,000 shares $82.90 million -4.8%N/A6.7 $10.71
5/15/20248,130,000 shares $105.20 million +23.2%N/A7 $12.94
4/30/20246,600,000 shares $116.16 million +0.9%N/A5.6 $17.60
4/15/20246,540,000 shares $139.17 million -4.5%N/A6.7 $21.28
3/31/20246,850,000 shares $141.59 million +4.1%N/A7.1 $20.67
3/15/20246,580,000 shares $141.34 million +15.0%N/A6.4 $21.48
2/29/20245,720,000 shares $155.64 million +20.4%N/A4.5 $27.21
2/15/20244,750,000 shares $138.13 million -7.6%N/A2.9 $29.08
1/31/20245,140,000 shares $138.42 million -1.2%N/A3.3 $26.93
1/15/20245,200,000 shares $118.35 million -2.4%N/A3.5 $22.76
12/31/20235,330,000 shares $123.18 million +12.2%N/A3.9 $23.11
12/15/20234,750,000 shares $92.86 million -32.2%N/A3.6 $19.55
11/30/20237,010,000 shares $43.81 million +28.9%25.0%5.9 $6.25
11/15/20235,440,000 shares $36.39 million +1.7%19.4%10.3 $6.69
10/31/20235,350,000 shares $32.21 million +9.0%19.2%10.3 $6.02
10/15/20234,910,000 shares $39.77 million -29.3%17.6%9.3 $8.10
9/30/20236,940,000 shares $55.45 million +12.3%25.1%11.6 $7.99
9/15/20236,180,000 shares $64.77 million +9.2%22.3%10.2 $10.48
8/31/20235,660,000 shares $56.09 million +12.1%20.6%9.5 $9.91
8/15/20235,050,000 shares $71.66 million +3.7%18.8%8.9 $14.19
7/31/20234,870,000 shares $60.88 million +1.9%N/A9.3 $12.50
7/15/20234,780,000 shares $52.44 million -7.7%N/A4.9 $10.97
6/30/20235,180,000 shares $45.07 million +7.5%N/A5.6 $8.70
6/15/20234,820,000 shares $32.73 million +13.2%18.4%5.3 $6.79
5/31/20234,260,000 shares $25.77 million +5.2%16.2%4.8 $6.05
5/15/20234,050,000 shares $24.30 million +11.3%15.4%4.7 $6.00
4/30/20233,640,000 shares $22.86 million -0.3%14.1%4.4 $6.28
4/15/20233,650,000 shares $15.80 million +9.3%14.2%5.3 $4.33
3/31/20233,340,000 shares $9.82 million +19.7%13.0%11 $2.94
3/15/20232,790,000 shares $6.67 million +34.8%10.9%10 $2.39
2/28/20232,070,000 shares $6.91 million No Change8.1%8.1 $3.34
2/15/20232,070,000 shares $7.66 million -4.2%8.1%8.5 $3.70
1/31/20232,160,000 shares $10.07 million +6.9%8.6%9.3 $4.66
1/15/20232,020,000 shares $10.18 million +13.5%8.0%9.4 $5.04
12/30/20221,780,000 shares $6.23 million +6.0%7.1%12.3 $3.50
12/15/20221,680,000 shares $4.50 million -2.9%6.7%11.6 $2.68
11/30/20221,730,000 shares $5.54 million -3.4%6.9%13.6 $3.20
11/15/20221,790,000 shares $7.91 million -9.1%7.1%14.1 $4.42
10/31/20221,970,000 shares $10.64 million -1.5%N/A16.1 $5.40
10/15/20222,000,000 shares $11.20 million -1.5%7.7%14.3 $5.60
9/30/20222,030,000 shares $16.06 million -0.5%7.8%12.5 $7.91
9/15/20222,040,000 shares $16.30 million +0.5%7.9%12.7 $7.99
8/31/20222,030,000 shares $20.30 million +1.5%7.8%12.7 $10.00
8/15/20222,000,000 shares $22.24 million -8.3%7.7%12.8 $11.12
From the man who predicted 2008 crash… (Ad)

Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the biggest story of his 26-year career - an economic shift not seen since 1776. From the government taking stakes in Intel, Lithium Americas, and MP Materials, to sweeping political changes reshaping the economy, Stansberry argues a rare 'New 1776 Moment' is already underway. One Nobel Prize winner calls it a dividing line for all of society. His presentation covers the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Watch Porter Stansberry's full briefing and learn how to prepare now
7/31/20222,180,000 shares $19.90 million +7.4%8.3%13.8 $9.13
7/15/20222,030,000 shares $20.12 million +1.0%7.8%14.4 $9.91
6/30/20222,010,000 shares $15.82 million +2.0%7.7%16.8 $7.87
6/15/20221,970,000 shares $15.62 million -5.3%7.5%16.7 $7.93
5/31/20222,080,000 shares $20.07 million -3.3%8.0%16 $9.65
5/15/20222,150,000 shares $21.26 million -1.4%8.2%14.1 $9.89
4/30/20222,180,000 shares $24.63 million +0.5%8.3%13.4 $11.30
4/15/20222,170,000 shares $27.54 million +0.5%8.3%11.9 $12.69
3/31/20222,160,000 shares $26.24 million +4.9%8.3%9.6 $12.15
3/15/20222,060,000 shares $24.82 million +3.0%7.9%7.9 $12.05
2/28/20222,000,000 shares $19.90 million +3.6%7.7%7.2 $9.95
2/15/20221,930,000 shares $19.59 million -2.5%7.4%6.6 $10.15
1/31/20221,980,000 shares $18.55 million -8.3%7.6%2.4 $9.37
1/15/20222,160,000 shares $21.45 million +11.3%N/A2.7 $9.93
12/31/20211,940,000 shares $23.75 million +0.5%7.4%2.5 $12.24
12/15/20211,930,000 shares $28.27 million -3.5%7.4%2.6 $14.65
11/30/20212,000,000 shares $31.60 million +98.0%8.1%2.9 $15.80
11/15/20211,010,000 shares $14.44 million -34.0%4.2%1.5 $14.30
10/29/20211,530,000 shares $17.55 million +10.9%7.3%11 $11.47
10/15/20211,380,000 shares $15.79 million +0.7%6.6%12.1 $11.44
9/30/20211,370,000 shares $14.28 million -3.5%6.5%11.3 $10.42
9/15/20211,420,000 shares $14.31 million +2.9%6.8%8.4 $10.08
8/31/20211,380,000 shares $15.10 million +4.6%6.6%8.2 $10.94
8/13/20211,320,000 shares $13.66 million -4.4%6.3%8 $10.35
7/30/20211,380,000 shares $11.34 million +5.3%6.6%8.1 $8.22
7/15/20211,310,000 shares $10.00 million +0.8%6.3%7 $7.63
6/30/20211,300,000 shares $11.69 million +14.0%6.2%6.6 $8.99
6/15/20211,140,000 shares $10.84 million -10.2%5.5%6.7 $9.51
5/28/20211,270,000 shares $12.48 million +3.3%6.1%6.6 $9.83

EYPT Short Interest - Frequently Asked Questions

Short interest is the volume of Eyepoint Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 14,186,473 shares of EYPT short. 17.72% of Eyepoint Pharmaceuticals' shares are currently sold short. Learn More on Eyepoint Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EYPT shares currently have a short interest ratio of 16.6. Learn More on Eyepoint Pharmaceuticals's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eyepoint Pharmaceuticals: Caption Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.72% of Eyepoint Pharmaceuticals' floating shares are currently sold short.

Eyepoint Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 14,186,473 shares, an increase of 3.9% from the previous total of 13,659,042 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

17.72% of Eyepoint Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Eyepoint Pharmaceuticals: Vontier Corporation (4.53%), Aehr Test Systems (16.09%), 10x Genomics (13.95%), Alamar Biosciences, Inc. (1.73%), Allient Inc. (5.58%), Transcat, Inc. (5.77%), Frequency Electronics, Inc. (13.06%), Cytek Biosciences, Inc. (6.69%), Standard BioTools Inc. (3.94%), Nautilus Biotechnology, Inc. (0.96%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling EYPT is an investing strategy that aims to generate trading profit from Eyepoint Pharmaceuticals as its price is falling. EYPT shares are trading down $0.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Eyepoint Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EYPT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EYPT, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like EYPT:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:EYPT) was last updated on 5/18/2026 by MarketBeat.com Staff.
From Our Partners
ZENA Surges: 558% Revenue Growth Fuels Breakout Small-Cap Narrative!
ZenaTech (NASDAQ: ZENA) reported $12.9 million in full-year 2025 revenue, representing 558% year-over-year gro...
Equiscreen | Sponsoredtc pixel
Musk’s warning just revealed a $1T opportunity
Elon Musk recently warned that AI could force governments to introduce universal income. Mode Mobile isn't wai...
Mode Mobile | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Your $29.97 book is free today
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel